Indicators
Indicators
Value
Direction
MACD(12,26,9)
3.484
Neutral
RSI(14)
47.808
Neutral
STOCH(KDJ)(9,3,3)
44.086
Neutral
ATR(14)
31.436
High Vlolatility
CCI(14)
82.681
Neutral
Williams %R
39.600
Buy
TRIX(12,20)
-0.267
Sell
StochRSI(14)
100.000
Buy
Intuitive Surgical Inc
ISRGView Detailed Chart
487.930USD
+9.190+1.92%
Close 04/23, 16:00（ET）Quotes delayed by 15 min
174.81BMarket Cap
75.27P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+1.92%
5 Days
+1.37%
1 Month
-0.93%
6 Months
-4.81%
Year to Date
-6.52%
1 Year
+29.40%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
33
analysts
BUY
Current Rating
600.915
Target Price
25.52%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
91
Total
4
Median
7
Average
Company name
Ratings
Analysts
Intuitive Surgical Inc
ISRG
33
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
33
Veeva Systems Inc
VEEV
32
Danaher Corp
DHR
28
1
2
3
...
18
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Neutral
Moving Average
Indicators
Value
Direction
MA5
479.814
Buy
MA10
488.335
Sell
MA20
487.912
Buy
MA50
521.578
Sell
MA100
538.443
Sell
MA200
511.559
Sell
News
Intuitive Surgical dips on slower procedure growth forecast
** Surgical robot maker Intuitive Surgical's ISRG.O shares fall 3.1% to $590.01 premarket, fourth biggest decliner among S&P 500 components before the bell ** ISRG expects the number of procedures using its da Vinci robots to grow between 13-16% in 2025, versus 17% growth in 2024, it said la...
ReutersFri, Jan 24
Intuitive Surgical beats quarterly profit estimates on strength in surgical robots business
Jan 23 (Reuters) - Intuitive Surgical ISRG.O beat Wall Street estimates for fourth-quarter profit on Thursday, driven by strong demand for its surgical robots used in minimally invasive procedures.The medical device maker reported an adjusted profit of $2.21 per share, beating analysts' estimate...
ReutersThu, Jan 23
Company
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Company codeISRG
CompanyIntuitive Surgical Inc
CEODr. Gary S. Guthart, Ph.D.
Websitehttps://www.intuitive.com/en-us/about-us/company
